Concerns about immunisation

British Medical Journal

Volumn 320, Issue 7229, 2000, Pages 240-243

  Bedford, Helen ^a   Elliman, David ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

HEALTH EDUCATION; HEALTH SERVICE; HUMAN; IMMUNIZATION; INFORMED CONSENT; PARENTAL BEHAVIOR; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0034700922     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.320.7229.240     Document Type: Short Survey

References (35)

1. 1 Plotkin SL, Plotkin SA. A short history of vaccination. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia: Saunders, 1999.
2. 2 McTaggart L. Measles, mumps and rubella. In: The vaccination bible. London: What Doctors Don't Tell You, 1998.
3. 3 Ramsey MEB, Gay N, Miller E, Rush M, While J, Morgan-Capner P, et al. The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev 1994:4(12):R141-6.
4. 4 Gill E, Sutton S. Immunisation uptake: the role of parental attitudes. In: Hey V, ed. Immunisaton research: a summary volume. London: Health Education Authority, 1998.
5. 5 Simpson N, Lenton S, Randall R. Parental refusal to have children immunised. BMJ 1995;310:227.
6. 6 Scheibner V. Vaccination - 100 years of orthodox research shows that vaccines represent a medical assault on the immune system. Victoria: Australian Print Group, 1993.
7. 7 Taylor M, ed. The informed parent. Harrow, Middlesex, 1999. (Newsletter.)
8. 8 Gaublomme K, ed. The international vaccination newsletter. Genk, Belgium, 1999. (Newsletter.)
9. 9 Communicable Disease Surveillance Centre. A case of diphtheria from Pakistan. Commun Dis Rep CDR Wkly 1994;4:37.
10. 10 Miller CL. Deaths from measles in England and Wales, 1970-83. BMJ 1985;290:443-4.
11. 11 Medical Research Council. The prevention of whooping-cough by vaccination. BMJ 1951;i:1463-71.
12. 12 Olin P, Rasmussen F, Gustaffson L, Hallander H, Heijbel H for the Ad Hoc Group for the Study of Pertussis Vaccines. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet 1997;350:1569-77.
13. 13 Simondon F, Preziosi MP, Yam A, Kane CT, Chabirand L, Iteman I, et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997;15:1606-12.
14. 14 Schlegel M, Osterwalder JL, Galeazza RL, Vernazza PL. Comparative efficacy of three mumps vaccines during disease outbreaks in eastern Switzerland: cohort study. BMJ 1999;319:352.
15. 15 Oostvogel PM, van Wijngaarden JK, van der Avoort HGAM, Mulders MN, Conyu-van Spaacudonck MAE, Rumke HC, et al. Poliomyelitis outbreak in an unvacrinated community in the Netherlands, 1992-93. Lancet 1994;344:665-70.
16. 16 Etkind P, Lett SM, Macdonald PD, Silva E, Peppe J. Pertussis outbreaks in groups claiming religious exemptions to vaccinations. Am J Dis Child 1992;146:173-6.
17. 17 Hutchins S, Markowitz L, Atkinson W, Swint E, Hadler S. Measles outbreaks in the United States, 1987 through 1990. Pediatr Infect Dis J 1996; 15:31-8.
18. 18 Mellinger AK, Cragan JD, Atkinson WL, Williams WW, Kleger B, Kimber RG, et al. High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr Infect Dis J 1995;14:573-8.
19. 19 De Serres G, Boulianne N, Meyer F, Ward BJ. Measles vaccine efficacy during an outbreak in a highly vaccinated populalion: incremental increase in protection with age at vaccination up to 18 months. Epidemiol Infect 1995;115:315-23.
20. 20 Kulenkampff MM, Schwartman JS, Wilson J. Neurological complications of pertussis inoculation. Arch Dis Child 1974;49:46-9.
21. 21 Gangarosa FJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE, Miller E, et al. Impact of anti-vaccine movements on pertussis control. Lancet 1998;351:356-61.
22. 22 Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:1327-8.
23. 23 Communicable Disease Surveillance Centre. MMR vaccine coverage falls in the United Kingdom. Commun Dis Rep CDR Wkly 1999;9:37.
24. 24 Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental? Lancet 1998;351:611-2.
25. 25 Gillberg C, Heijbel H, MMR and autism. Int J Res Pract 1998;2:423-4.
26. 26 Peltola H, Palja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence tor measles, mumps and rubella vaccine associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998;351:1327-8.
27. 27 Taylor BME, Farrington CP, Petropoulos M-C, Favot-Mayaud I, Li J, Waight PA. Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353: 2026-9.
28. 28 Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan Capner P, et al. A new method for active surveillance of adverse events from diphtheria/ tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995;345:567-9.
29. 29 Odent MR, Culpin EE, Kimmel T. Pertussis vaccination and asthma: is there a link? JAMA 1994;272:592-3.
30. 30 Nilsson L, Kjellman N-IM, Storsaeter J, Gustafsson L, Olin P. Lack of association between pertussis vaccination and symptoms of asthma and allergy. JAMA 1990;275:760.
31. 31 Department of Health. Immunisation against infectious disease. London: HMSO, 1996.
32. 32 Begg N, Nicoll A. Myths in medicine - immunisation. BMJ 1994;309: 1073-5.
33. 33 English JM. Pertussin 30 - preventive for whooping cough? Br Homeopath J 1987;76:61-5.
34. 34 Fisher P. Enough nonsense on immunization. Br Homeopath J 1990;79: 198-200.
35. 35 Hahnemann S. Organon of medicine, 6th ed. Los Angeles: JP Tarcher, 1982.